Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Shun-Qing Liang · SciRah

Researcher profile · Semantic Scholar

Shun-Qing Liang

Share profile

Shun-Qing Liang — researcher profile on SciRah

h-index: 12
Works: 18
Citations: 444

Most-cited papers

New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
Hai-Xia Yang, Shun-Qing Liang, R. Schmid, R. Peng
2019Frontiers in Oncology116 citations Open access
Semantic Scholar
HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer
Hai-Xia Yang, Shun-Qing Liang, Duo Xu, Zhang Yang +6 more
2019Oncogenesis54 citations Open access
Semantic Scholar
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer
Shun-Qing Liang, Elias D. Bührer, S. Berezowska, T. Marti +12 more
2018Oncogene49 citations
Semantic Scholar
Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma
Duo Xu, Shun-Qing Liang, Hai-Xia Yang, Ursina Lüthi +8 more
2018British Journal of Cancer34 citations Open access
Semantic Scholar
Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer
Zhang Yang, Shun-Qing Liang, Liang Zhao, Hai-Xia Yang +10 more
2022Journal of experimental & clinical cancer research : CR31 citations Open access
Semantic Scholar
CRISPR Screening Identifies WEE1 as a Combination Target for Standard Chemotherapy in Malignant Pleural Mesothelioma
Duo Xu, Shun-Qing Liang, Hai-Xia Yang, R. Bruggmann +8 more
2019Molecular Cancer Therapeutics29 citations Open access
Semantic Scholar
Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma
Duo Xu, Hai-Xia Yang, Zhang Yang, S. Berezowska +8 more
2019Cancers28 citations Open access
Semantic Scholar
Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS‐mutant cancer
Zhang Yang, Shun-Qing Liang, Maria Saliakoura, Hai-Xia Yang +13 more
2021EMBO Molecular Medicine25 citations Open access
Semantic Scholar
CRISPR-Mediated Kinome Editing Prioritizes a Synergistic Combination Therapy for FGFR1-Amplified Lung Cancer
Zhang Yang, Shun-Qing Liang, Hai-Xia Yang, Duo Xu +10 more
2021Cancer Research22 citations Open access
Semantic Scholar
Malignant pleural mesothelioma co-opts BCL-XL and autophagy to escape apoptosis
Duo Xu, Shun-Qing Liang, Zhang Yang, Hai-Xia Yang +9 more
2021Cell Death and Disease19 citations Open access
Semantic Scholar
Analysis of unexpected small cell lung cancer following surgery as the primary treatment
Hai-Xia Yang, Jian-Lin Xu, F. Yao, Shun-Qing Liang +1 more
2018Journal of Cancer Research and Clinical Oncology19 citations Open access
Semantic Scholar
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma
Hai-Xia Yang, Yan-Yun Gao, Duo Xu, Ke Xu +13 more
2023Cell Death Discovery13 citations Open access
Semantic Scholar
Crispr-mediated genome editing reveals a preponderance of non-oncogene addictions as targetable vulnerabilities in pleural mesothelioma.
Duo Xu, Shun-Qing Liang, Min Su, Hai-Tang Yang +10 more
2024Lung Cancer4 citations Open access
Semantic Scholar
Distinct molecular subtypes of KRASG12C ‐mutant lung adenocarcinoma: Insights into clinical outcomes, tumour microenvironments and therapeutic strategies
Hai-Tang Yang, Anshun Zhu, Yongliang Niu, Wen-Yan Ma +11 more
2025Clinical and Translational Medicine1 citations Open access
Semantic Scholar
Epithelial‐to‐mesenchymal transition (EMT) is required for resistance to anti‐folate chemotherapy in lung cancer: 18P
Shun-Qing Liang, T. Marti, P. Dorn, L. Froment +5 more
2016Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
Therapeutic Targeting of MEK1/2 Synergizes with PARP1 Inhibitors in the Treatment of Malignant Pleural Mesothelioma
Hai-Xia Yang, Yan-Yun Gao, Duo Xu, Shun-Qing Liang +12 more
2022Social Science Research Network0 citations
Semantic Scholar
Malignant pleural mesothelioma co-opts BCL-XL and autophagy to escape apoptosis
Duo Xu, Shun-Qing Liang, Zhang Yang, Hai-Xia Yang +9 more
2021Cell Death and Disease0 citations Open access
Semantic Scholar
Combined mTOR inhibition and chemotherapy as an effective strategy to treat KRAS-mutant lung cancer
Ren-Wang Peng, Shun-Qing Liang, Elias D. Bührer, S. Berezowska +12 more
2019Zentralblatt für Chirurgie0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Peng×16
Invite
R. Peng — researcher profile on SciRah
Hai-Xia Yang×15
Invite
Hai-Xia Yang — researcher profile on SciRah
T. Marti×15
Invite
T. Marti — researcher profile on SciRah
R. Schmid×14
Invite
R. Schmid — researcher profile on SciRah

×14

Invite

G. Kocher — researcher profile on SciRah

Invite

Duo Xu — researcher profile on SciRah

Invite

Zhang Yang — researcher profile on SciRah

S. Berezowska×11

Invite

S. Berezowska — researcher profile on SciRah

Invite

S. Hall — researcher profile on SciRah

Yan-Yun Gao×7

Invite

P. Dorn — researcher profile on SciRah

R. Bruggmann×5

Invite

R. Bruggmann — researcher profile on SciRah